Pages that link to "Q40883127"
Jump to navigation
Jump to search
The following pages link to Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis (Q40883127):
Displaying 50 items.
- Primary biliary cirrhosis (Q21202919) (← links)
- Cystic Fibrosis Adult Care (Q22306058) (← links)
- Ursodeoxycholic acid for primary biliary cirrhosis (Q24202184) (← links)
- Ursodeoxycholic acid for primary biliary cirrhosis (Q24241945) (← links)
- Brazilian society of hepatology recommendations for the diagnosis and management of autoimmune diseases of the liver (Q26766699) (← links)
- Recurrence of autoimmune liver diseases after liver transplantation (Q26774539) (← links)
- Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis: a Review Featuring a Women's Health Perspective (Q26781780) (← links)
- Liver Transplantation for Patients with Cholestatic Liver Diseases (Q26782863) (← links)
- Primary biliary cirrhosis: From bench to bedside (Q26799419) (← links)
- The diagnosis of primary biliary cirrhosis (Q26829493) (← links)
- Primary biliary cirrhosis and liver transplantation (Q26853145) (← links)
- Primary biliary cirrhosis: Pathophysiology, clinical presentation and therapy (Q26853649) (← links)
- Primary biliary cirrhosis: Clinical and laboratory criteria for its diagnosis (Q26992087) (← links)
- A large-scale, multicentre, double-blind trial of ursodeoxycholic acid in patients with chronic hepatitis C (Q27482028) (← links)
- Optimal drug regimens for primary biliary cirrhosis: a systematic review and network meta-analysis (Q28087211) (← links)
- Intrahepatic cholestasis of pregnancy: molecular pathogenesis, diagnosis and management (Q28141076) (← links)
- Bcl-2-dependent oxidation of pyruvate dehydrogenase-E2, a primary biliary cirrhosis autoantigen, during apoptosis (Q28344126) (← links)
- Stimulation of ATP secretion in the liver by therapeutic bile acids (Q28345188) (← links)
- Ursodeoxycholic acid therapy in hepatobiliary disease (Q28377666) (← links)
- Ursodeoxycholic acid suppresses extent of lipid peroxidation in diseased liver in experimental cholestatic liver disease (Q31704415) (← links)
- Bile acid abnormalities in cholestatic liver diseases (Q33591450) (← links)
- Mechanism of hepatoprotective action of bile salts in liver disease (Q33591454) (← links)
- Review article: mechanisms of action and therapeutic applications of ursodeoxycholic acid in chronic liver diseases (Q33723536) (← links)
- Recurrent primary biliary cirrhosis: peritransplant factors and ursodeoxycholic acid treatment post-liver transplant (Q33730935) (← links)
- Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis (Q33745849) (← links)
- Ursodeoxycholic acid treatment of vanishing bile duct syndromes (Q33866782) (← links)
- Primary biliary cirrhosis: new perspectives in diagnosis and treatment (Q33869324) (← links)
- Chronic cholestatic diseases (Q33870255) (← links)
- URSO-panacea or placebo? (Q33873354) (← links)
- Prognostic Factors for Transplant-Free Survival and Validation of Prognostic Models in Chinese Patients with Primary Biliary Cholangitis Receiving Ursodeoxycholic Acid (Q33920325) (← links)
- Medical treatment of cholestatic liver diseases: From pathobiology to pharmacological targets (Q34017604) (← links)
- Treatment of primary biliary cirrhosis and primary sclerosing cholangitis: use of ursodeoxycholic acid (Q34027595) (← links)
- Biliary tract inflammatory disorders: primary sclerosing cholangitis and primary biliary cirrhosis (Q34027631) (← links)
- Hepatology in the new millennium. Advances in viral hepatitis, hepatic disorders, and liver transplantation (Q34057526) (← links)
- Biliary physiology and disease: reflections of a physician-scientist (Q34108895) (← links)
- Primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune cholangitis (Q34170438) (← links)
- Treatment Options for Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis (Q34182672) (← links)
- Primary biliary cirrhosis and primary sclerosing cholangitis (Q34210604) (← links)
- Hepatic fibrosis. Pathogenesis and principles of therapy (Q34269628) (← links)
- Primary biliary cirrhosis and autoimmune cholangiopathy (Q34310808) (← links)
- Ursodeoxycholic acid 'mechanisms of action and clinical use in hepatobiliary disorders'. (Q34330984) (← links)
- Options for treatment of primary biliary cirrhosis (Q34354186) (← links)
- Treatment of primary biliary cirrhosis (Q34398020) (← links)
- Current status of therapy in autoimmune liver disease (Q34408950) (← links)
- Recent advances in the development of farnesoid X receptor agonists (Q34464043) (← links)
- The therapeutic effects of ursodeoxycholic acid as an anti-apoptotic agent (Q34481547) (← links)
- Use of ursodeoxycholic acid in patients with liver disease (Q34515643) (← links)
- Long-term effects of mid-dose ursodeoxycholic acid in primary biliary cirrhosis: a meta-analysis of randomized controlled trials (Q34550505) (← links)
- Administration of tauroursodeoxycholic acid (TUDCA) reduces apoptosis following myocardial infarction in rat. (Q34619432) (← links)
- Pathogenesis of Cholestatic Liver Disease and Therapeutic Approaches (Q34623557) (← links)